J. Strange et Ra. Roberts, REDUCED EXPRESSION OF MATURE TGF-BETA-1 CORRELATES WITH THE SUPPRESSION OF RAT HEPATOCYTE APOPTOSIS BY THE PEROXISOME PROLIFERATOR, NAFENOPIN, Mutation research, 372(1), 1996, pp. 107-113
Non-genotoxic carcinogens cause cancer without damaging the DNA. Perox
isome proliferators (PPs) are a class of potent rodent non-genotoxic h
epatocarcinogens that may act by perturbing hepatocyte growth regulati
on. Previously, we have shown that although cultured rat hepatocytes d
egenerate rapidly in culture, their survival can be reversibly maintai
ned by the PP nafenopin. This prolonged survival is associated with a
decrease in the number of hepatocytes displaying the chromatin condens
ation characteristic of apoptosis. The addition of the negative growth
regulator TGF beta-1 induced high levels of hepatocye apoptosis but n
afenopin was able to suppress this TGF beta-1 induced apoptosis. These
data suggested that increased levels of mature TGF beta-1 may be invo
lved in the signalling of the apoptosis seen in degenerating hepatocyt
e cultures. To test this hypothesis, we carried out Western blot analy
ses using a anti-TGF beta 1 antibody. There was an increase (p = 0.014
) in expression of mature TGF beta 1 in degenerating rat hepatocyte cu
ltures compared with hepatocyte cultures surviving in the presence of
nafenopin. However, there was a concommitant decrease (p = 0.024) in T
GF beta 1-latency activated protein (TGF beta 1-LAP), the precursor of
the active, mature form. Immunocytochemistry confirmed that TGF beta
1/TGF beta 1-LAP expression was predominantly in the hepatocytes displ
aying apoptotic morphology although expression was detected also in no
n-parenchymal liver cells. The immunocytochemistry data indicate that
TGF beta 1 is involved during the onset of hepatocyte apoptosis and th
at the PP nafenopin can impinge on this cell death pathway. TGF beta 1
-LAP, probably produced mainly by the non-parenchymal liver cells, may
be processed less efficiently to the mature, active form in the prese
nce of nafenopin, although more data are required to confirm this hypo
thesis.